The Trump administration's sweeping foreign aid cuts will send tuberculosis cases and deaths soaring around the world, humanitarian workers have warned.
One told AFP that people are already dying from a lack of treatment in the conflict-torn Democratic Republic of Congo (DRC).
The United States has long been the biggest funder for the global fight against tuberculosis -- once known as consumption -- which is again the world's biggest infectious disease killer after being briefly surpassed by COVID-19.
But President Donald Trump froze U.S. foreign aid after returning to the White House in January, abruptly halting the work of many U.S.-funded programs against tuberculosis and other health scourges such as HIV and malaria.
Trump's billionaire advisor Elon Musk has boasted of putting the vast U.S. humanitarian agency USAID "through the woodchipper".
On Monday, U.S. Secretary of State Marco Rubio announced that 83 percent of all USAID contracts were officially canceled. It was unclear which programs would be spared.
The World Health Organization warned last week that the cuts would endanger millions of lives, pointing out that tuberculosis (TB) efforts averted 3.65 million deaths last year alone.
The change has already brought about a major impact in many developing countries, according to aid workers and activists on the ground.
In the Democratic Republic of Congo, many frontline community workers have been forced to stop helping tuberculosis patients, said Maxime Lunga, who heads a local group called Club des Amis.
Even before the U.S. funding cuts, there was shortage of TB drugs in the country, which is also facing outbreaks of mpox, as well as a mystery illness and a surge in fighting in its conflict-plagued east.
"The chaotic situation is starting to get scary here," said Lunga, who is himself a tuberculosis survivor.
"Right now we are receiving a lot of phone calls from patients asking us how to help them access care," he told AFP.
"We know that some of the patients on waiting lists are now dying because they are not being treated."
'People will suffer'
In Ukraine, another conflict-battered nation with high TB rates, a program to teach children about the dangers of tuberculosis was just three days from starting in schools when the U.S. order to stop work came in.
Olya Klymenko, whose group TB People Ukraine spent two years setting up the program, lamented that the money had been wasted.
It was, she said, a "very bad deal".
Klymenko feared the U.S. cuts would reverse the gains that have been made since she survived TB a decade ago.
"As a person who started receiving treatment when the old approaches were used, I know perfectly well what we have lost now," she told AFP.
"People will suffer a lot."
Lunga and Klymenko's organizations both received U.S. funds through the Stop TB Partnership.
The Geneva-based NGO received a letter from the U.S. government terminating all funding late last month.
It had to share the bad news with 150 community organizations that test, treat, and care for patients in affected countries.
Then Stop TB received a new letter last week rescinding the termination.
"The new letter clearly indicates that all work should resume as planned," the organization's executive director, Lucica Ditiu, told AFP.
But it was still unclear whether the decision was permanent -- or when any new U.S. money would actually be released, she added.
'Snowball effect'
Allowing airborne TB to go untested and untreated could have a "snowball effect" across the world, Ditiu warned.
There are already mutated forms of TB that are resistant to most drugs, and Ditiu feared the U.S. cuts could result in a bug that no treatment can stop.
"Interrupting a treatment for a drug-resistant TB person is horrible, because it will create a bug that will be spread through the air, so me and you and our families or friends can get it," she warned.
The funding cuts were particularly "devastating" because 2024 was the "best year ever" for the fight against TB, Ditiu added.
According to an internal USAID memo by a now-dismissed assistant administrator, the aid cuts will cause rates of tuberculosis and drug-resistant TB to both surge by roughly 30 percent.
"The U.S. will see more cases of hard-to-treat TB arriving at its doorstep," according to the memo, published in the New York Times earlier this month.
The U.S. is already reportedly experiencing the largest TB outbreak in its modern history in Kansas City.
A humanitarian source in Geneva who wished to remain anonymous told AFP the situation was "very dangerous, even for the European Union" because of the risk linked to drug-resistant TB in Ukraine and Georgia.